Chungen Li

626 total citations
34 papers, 466 citations indexed

About

Chungen Li is a scholar working on Molecular Biology, Infectious Diseases and Electronic, Optical and Magnetic Materials. According to data from OpenAlex, Chungen Li has authored 34 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Infectious Diseases and 5 papers in Electronic, Optical and Magnetic Materials. Recurrent topics in Chungen Li's work include Biochemical and Molecular Research (5 papers), Ubiquitin and proteasome pathways (4 papers) and HIV/AIDS drug development and treatment (4 papers). Chungen Li is often cited by papers focused on Biochemical and Molecular Research (5 papers), Ubiquitin and proteasome pathways (4 papers) and HIV/AIDS drug development and treatment (4 papers). Chungen Li collaborates with scholars based in China, United States and Hong Kong. Chungen Li's co-authors include Youfu Luo, Haoqing Hou, Shuiliang Chen, Tao Yang, Hua Zhang, Haimin Yao, Yan Zhou, Lang Liu, Shuwu Liu and Qi An and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and Carbon.

In The Last Decade

Chungen Li

34 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chungen Li China 13 141 86 77 71 59 34 466
Longjie Wang China 16 199 1.4× 124 1.4× 247 3.2× 20 0.3× 56 0.9× 97 897
Gihyeon Kim South Korea 12 235 1.7× 98 1.1× 353 4.6× 94 1.3× 123 2.1× 27 912
Pei‐Jane Tsai Taiwan 10 248 1.8× 42 0.5× 234 3.0× 83 1.2× 102 1.7× 20 727
Wen-Chien Huang Taiwan 11 116 0.8× 41 0.5× 87 1.1× 66 0.9× 15 0.3× 26 354
Pan Kee Bae South Korea 15 166 1.2× 88 1.0× 132 1.7× 31 0.4× 14 0.2× 33 634
Huiyan Zhang China 13 64 0.5× 58 0.7× 122 1.6× 108 1.5× 36 0.6× 39 410
Wenjing Ma China 14 108 0.8× 68 0.8× 138 1.8× 85 1.2× 11 0.2× 38 467
Wajid Hussain China 11 98 0.7× 79 0.9× 162 2.1× 110 1.5× 91 1.5× 41 466

Countries citing papers authored by Chungen Li

Since Specialization
Citations

This map shows the geographic impact of Chungen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chungen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chungen Li more than expected).

Fields of papers citing papers by Chungen Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chungen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chungen Li. The network helps show where Chungen Li may publish in the future.

Co-authorship network of co-authors of Chungen Li

This figure shows the co-authorship network connecting the top 25 collaborators of Chungen Li. A scholar is included among the top collaborators of Chungen Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chungen Li. Chungen Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Cong, et al.. (2024). The association between the triglyceride-glucose index and sarcopenia: data from the NHANES 2011–2018. Lipids in Health and Disease. 23(1). 219–219. 18 indexed citations
2.
Parolia, Abhijit, Yihan Liu, Yuanyuan Qiao, et al.. (2024). Discovery of LLC0424 as a Potent and Selective in Vivo NSD2 PROTAC Degrader. Journal of Medicinal Chemistry. 67(9). 6938–6951. 13 indexed citations
3.
Li, Chungen, Yihan Chen, Weixue Huang, et al.. (2024). Structure-Based Design of “Head-to-Tail” Macrocyclic PROTACs. SHILAP Revista de lepidopterología. 4(12). 4866–4882. 8 indexed citations
4.
Li, Chungen, Yuanyuan Qiao, Xia Jiang, et al.. (2023). Discovery of a First-in-Class Degrader for the Lipid Kinase PIKfyve. Journal of Medicinal Chemistry. 66(17). 12432–12445. 10 indexed citations
5.
Li, Chungen, Yue Zhou, Jing Xu, et al.. (2022). Discovery of potent human dihydroorotate dehydrogenase inhibitors based on a benzophenone scaffold. European Journal of Medicinal Chemistry. 243. 114737–114737. 7 indexed citations
6.
Li, Cong, Song Liu, Chungen Li, et al.. (2022). Discovery and Mechanistic Study of Mycobacterium tuberculosis PafA Inhibitors. Journal of Medicinal Chemistry. 65(16). 11058–11065. 7 indexed citations
7.
Yang, Xiaowei, Chungen Li, Kun Gou, et al.. (2022). A novel and potent dihydroorotate dehydrogenase inhibitor suppresses the proliferation of colorectal cancer by inducing mitochondrial dysfunction and DNA damage. SHILAP Revista de lepidopterología. 1(1). 3 indexed citations
8.
An, Qi, Xiaofei Shen, Chungen Li, et al.. (2021). Structure-Guided Design of the First Noncovalent Small-Molecule Inhibitor of CRM1. Journal of Medicinal Chemistry. 64(10). 6596–6607. 20 indexed citations
9.
Li, Chungen, Liang Wang, Qingsong Jiang, et al.. (2021). A Novel Small Molecule, LCG-N25, Inhibits Oral Streptococcal Biofilm. Frontiers in Microbiology. 12. 654692–654692. 12 indexed citations
10.
Li, Chungen, Xiaowei Yang, Yuan Luo, et al.. (2021). Design, Synthesis, and Biological Evaluation of a Novel Series of Teriflunomide Derivatives as Potent Human Dihydroorotate Dehydrogenase Inhibitors for Malignancy Treatment. Journal of Medicinal Chemistry. 64(24). 18175–18192. 8 indexed citations
12.
An, Qi, Chungen Li, Liangxue Zhou, et al.. (2020). Scaffold hopping of agomelatine leads to enhanced antidepressant effects by modulation of gut microbiota and host immune responses. Pharmacology Biochemistry and Behavior. 192. 172910–172910. 16 indexed citations
13.
An, Qi, Chungen Li, Yao Chen, et al.. (2020). Repurposed drug candidates for antituberculosis therapy. European Journal of Medicinal Chemistry. 192. 112175–112175. 39 indexed citations
14.
Chen, Yao, Yuan Ju, Chungen Li, et al.. (2019). Design, synthesis, and antibacterial evaluation of novel derivatives of NPS-2143 for the treatment of methicillin-resistant S. aureus (MRSA) infection. The Journal of Antibiotics. 72(7). 545–554. 7 indexed citations
15.
16.
Li, Chungen, Zitai Sang, Yang Yang, et al.. (2019). Discovery of napabucasin derivatives for the treatment of tuberculosis. MedChemComm. 10(9). 1635–1640. 7 indexed citations
17.
Li, Chungen, Caili Chen, Qi An, et al.. (2018). A novel series of napabucasin derivatives as orally active inhibitors of signal transducer and activator of transcription 3 (STAT3). European Journal of Medicinal Chemistry. 162. 543–554. 33 indexed citations
18.
Ma, Danyang, Chungen Li, Lei Wang, et al.. (2017). Preparation of RE2O2SO4 (RE=La, Pr-Lu) microspheres from rare-earth-based infinite coordination polymers. Journal of Nanoparticle Research. 19(10). 6 indexed citations
19.
20.
Liu, Lang, Qi Xiong, Chungen Li, Feng Yan, & Shuiliang Chen. (2015). Conversion of straw to nitrogen doped carbon for efficient oxygen reduction catalysts in microbial fuel cells. RSC Advances. 5(109). 89771–89776. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026